, Tracking Stock Market Picks
Enter Symbol:
Cadence Pharmaceuticals, Inc. (CADX) [hlAlert]

up 153.72 %

Cadence Pharmaceuticals, Inc. (CADX) rated Buy with price target $12 by Canaccord Adams

Posted on: Friday,  Mar 13, 2009  11:25 AM ET by Canaccord Adams

Canaccord Adams rated Buy Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) on 03/13/2009. Previously Canaccord Adams rated Buy Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) on
01/31/2008., when the stock price was $5.51. Since then, Cadence Pharmaceuticals, Inc. has gained 153.72% as of 03/18/2014's recent price of $13.98.
If you would have followed the previous Canaccord Adams's recommendation on CADX, you would have gained 153.72% of your investment in 2238 days.

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing its product candidates principally for use in the hospital setting. The Company has in-licensed rights to two late stage product candidates, Acetavance a intravenous formulation of acetaminophen and Omigard (omiganan pentahydrochloride) 1% aqueous gel. It has in-licensed the exclusive United States and Canadian rights to Acetavance, that is marketed in Europe for the treatment of acute pain and fever by Bristol-Myers Squibb Company (BMS). The Company has also in-licensed the rights to commercialize Omigard in North American and Europe.

Canaccord Adams provides focused, actionable, idea-driven research, helping clients make informed investment decisions. Our 55 international analysts scour the globe for emerging and small to mid cap (US$1-2 billion market capitalization) growth opportunities, identifying value and exposing risk. Our research team analyzes over 550 companies in eight sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. Our clients benefit from our thorough and sophisticated knowledge of the sectors we cover - Metals and Mining, Energy, Technology, Life Sciences, Real Estate, Consumer, Sustainability and Industrial Growth. We combine independent, actionable ideas, unique global perspective and unparalleled industry expertise. We believe it's evident in our research, and the foundation of our business.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/13/2009 11:25 AM Buy
6.78 12.00
as of 12/31/2009
1 Week down  -25.77 %
1 Month down  -16.18 %
3 Months down  -34.90 %
1 YTD down  -0.41 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/31/2008 11:25 AM Buy
10.27 15.00
3/13/2008 12:25 PM Buy
5.75 11.00
1/31/2008 11:25 AM Buy
5.51 13.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy